Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 22, 2026

The stock of Dr Reddys Laboratories Ltd suffered a -0.15% drop, and it's now trading at 1280.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1280.40. The stock has a PE ratio of 19.3500, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, a situation worth noting. At present, the stock is trading at 1280.40. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.3500, while the industry PE ratio is 31.8257.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.15%, reaching a current market price of 1280.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.15% in its share price, and it currently trades at 1280.40 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd plunged by -0.15%, leaving investors concerned. At this moment, the stock can be acquired at 1280.40, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now at 1280.40. The stock is currently trading at a PE of 19.3500, while the industry PE is 31.8257, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.15%, reaching a current market price of 1280.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at 1280.40, and market participants are assessing the implications. The stock has a PE ratio of 19.3500, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, a situation worth noting. At present, the stock is trading at 1280.40. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.3500, while the industry PE ratio is 31.8257.

The share price of Dr Reddys Laboratories Ltd experienced a -0.15% slump and is currently trading at 1280.40. While the stock maintains a PE ratio of 19.3500, the industry PE is 31.8257, raising questions about valuation.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now at 1280.40. The stock is currently trading at a PE of 19.3500, while the industry PE is 31.8257, prompting investors to assess its value proposition.